Type 1 Diabetes
Day-and-night hybrid closed-loop insulin delivery improves glucose control compared with sensor-augmented pump therapy.
Repeated exposure to high levels of HbA1c was associated with increased risk for dementia in a cohort of patients age ≥50 with type 1 diabetes.
WHO has developed guidelines for selecting therapy for treatment intensiﬁcation in type 2 diabetes and on the use of insulin in type 1 and 2 diabetes in resource-poor settings.
Researchers found that patients with T1DM and poor glycemic control were more frequently diagnosed with infections.
Excess risk differed by up to 5 times across different diagnosis age groups.
The PedsQL 3.2 can assist in identify new and existing therapeutic interventions for individuals with different diabetes-specific health-related quality of life profiles.
It is critical for us to remember that children are not little adults. Pediatric-onset diabetes is different from adult-onset diabetes due to its distinct epidemiology, pathophysiology, developmental considerations, and response to therapy.
The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.
In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.
Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis.
Deficits similar for long-term type 1 diabetes and age-matched patients with type 2 diabetes
Per-person diabetes-attributable costs ranged from 374 in New Mexico to 1,610 in Washington, D.C.
A survey of individuals with type 1 diabetes mellitus consuming a very low-carbohydrate diet indicated that many study participants were able to maintain glycemic control within national ideal glycemic target ranges.
Artificial pancreas treatments are safe and effective for managing type 1 diabetes.
The CDC conducted a study to estimate the prevalence of diagnosed diabetes among adults in 2016 by primary type.
Oral insulin usage does not prevent the development of type 1 diabetes in relatives of patients.
Insulin pump therapy is linked to lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than insulin injection therapy.
However, long-term type 1 diabetes is associated with hand pain, disability, and stiffness.
A 36-year-old man with type 1 diabetes presents to the emergency room with hyperglycemia and possible diabetic ketoacidosis after not taking his insulin for 3 days.
The FDA approves an "artifical pancreas" for patients over 14 years of age.
Pediatric patients with type 1 diabetes often have low levels of vitamin D.
The ADA has published the 2016 Standards of Medical Care in Diabetes that outline the best practices for diabetes care and management.
Intranasal glucagon is noninferior to intramuscular glucagon in adults with type 1 diabetes.
While undergoing physical therapy after a stroke, a patient with type 1 diabetes has a hypoglycemia-related stroke.
Research shows that adding metformin to insulin therapy will not boost glycemic control in overweight teens with type 1 diabetes.
For people with type 1 diabetes, using insulin pump therapy lowers mortality from all causes.
After adjustment for age and sex, standardized mortality ratios (SMRs) were higher in type 1 and type 2 diabetes for all outcomes.
The patient, aged 69 years, had a 43-year history of type 1 diabetes and was scheduled to undergo a chest wall resection.
Clinicians should educate families about insulin omission as a weight-reduction strategy in adolescent girls with type 1 diabetes.
The incidence of diabetic ketoacidosis in children in Colorado at the time of type 1 diabetes diagnosis increased by 55% from 1998 to 2012.